BioSpace News Archive

BioMidwest

Transaction Data Systems Releases Patient Intake Functionality Alongside Readiness Requirements for the COVID-19 Booster

Transaction Data Systems (TDS), the leader in pharmacy software solutions, today announced that their pharmacy management systems are fully functional to dispense, bill, and report the third dose with the ease of new automated patient intake functionality.

August 24, 2021
·
3 min read
Drug Development

Tryp Therapeutics Completes Psychotherapy Training for Phase 2a Study at the University of Florida

The training, conducted by Fluence, represents a best-in-class approach for psychotherapy that will accompany the administration of psilocybin for overeating disorders.

August 24, 2021
·
5 min read
Business

GenScript Biotech Reports First Half 2021 Results

GenScript Biotech Corporation today reported its first half 2021 financial results for the six months ended June 30.

August 24, 2021
·
9 min read
Autism Therapy Market Size, Competitive Landscape, Key Country Analysis and Forecasts to 2028

Autism, it is also known as autism spectrum disorder (ASD). It is refers to a broad range of conditions that are characterized by challenges including nonverbal communication, speech, social skills, and repetitive behaviors.

August 24, 2021
·
4 min read
Genetown

New England Biolabs® Introduces Updated Versions of WarmStart® LAMP Reagents

New England Biolabs (NEB ® ) announces the release of its newest loop-mediated isothermal amplification (LAMP) products: the WarmStart Multi-Purpose LAMP/RT-LAMP 2X Master Mix

August 24, 2021
·
3 min read
Business

Awakn Life Sciences Initiates the First Ketamine Treatment Study for Gambling Addiction Led by Professor Celia Morgan

Recruitment Has Commenced for the First-Of-Its-Kind, U.K. - based Study, Led by Renowned Ketamine Researcher.

August 24, 2021
·
6 min read
FDA

Vifor Pharma and Cara Therapeutics announce U.S. FDA approval of KORSUVA™ injection for the treatment of moderate-to-severe pruritus in hemodialysis patients

Vifor Pharma and Cara Therapeutics announced that the U.S. Food and Drug Administration has approved KORSUVA™ for injection for the treatment of moderate-to-severe pruritus associated with chronic kidney disease in adults undergoing hemodialysis.

August 24, 2021
·
10 min read
Drug Development

Meiji Completed Phase I Studies and Moves Onto Phase II Study of ME3183, a Selective PDE4 Inhibitor for the Treatment of Psoriasis

Meiji Seika Pharma Co., Ltd.* announced that it has successfully completed Phase I clinical trials of ME3183, a selective PDE4 inhibitor, conducted in the United States.

August 24, 2021
·
1 min read
Ultrasonic Tissue Ablation System Market: Rise in Number of People Living with Various Types of Disease Conditions to Drive the Market

The global ultrasonic tissue ablation system market is poised to grow at prodigious rate during the forecast period of 2019 to 2027.

August 24, 2021
·
4 min read
Ovocytarian Puncture Needles Market: An increase in the prevalence of hormonal disorders to drive the market

Ovarian cyst is also called cystic ovarian mass. Common causes of ovarian cysts include hormonal problems, pregnancy, severe pelvic infections, and endometriosis.

August 24, 2021
·
5 min read